98 related articles for article (PubMed ID: 8749042)
1. Enhancement by nifedipine of cholinergic-induced depression of locomotor activity in mice.
Sansone M; Battaglia M; Pavone F
Funct Neurol; 1995; 10(4-5):163-7. PubMed ID: 8749042
[TBL] [Abstract][Full Text] [Related]
2. Shuttle-box avoidance behavior of mice treated with nifedipine in combination with nicotine or physostigmine.
Sansone M; Battaglia M; Vetulani J
Pol J Pharmacol; 1994; 46(3):169-73. PubMed ID: 8000449
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of cholinergic analgesia by nifedipine.
Pavone F; Battaglia M; Sansone M
Brain Res; 1993 Oct; 623(2):308-10. PubMed ID: 8221114
[TBL] [Abstract][Full Text] [Related]
4. The post-training memory enhancement induced by physostigmine and oxotremorine in mice is not state-dependent.
Baratti CM; Kopf SR
Neurobiol Learn Mem; 1996 Mar; 65(2):121-4. PubMed ID: 8833101
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of the type 2 and 3 inositol 1,4,5-trisphosphate receptors suppresses muscarinic antinociception in mice.
Galeotti N; Quattrone A; Vivoli E; Bartolini A; Ghelardini C
Neuroscience; 2007 Oct; 149(2):409-20. PubMed ID: 17890015
[TBL] [Abstract][Full Text] [Related]
6. Nifedipine-morphine interaction: a further investigation on nociception and locomotor activity in mice.
Pavone F; Battaglia M; Sansone M
J Pharm Pharmacol; 1992 Sep; 44(9):773-6. PubMed ID: 1360534
[TBL] [Abstract][Full Text] [Related]
7. Pituitary-adrenal responses to cholinergic stimulation and acute mild stress are differentially elevated in male and female M(2) muscarinic receptor knockout mice.
Rhodes ME; Billings TE; Czambel RK; Rubin RT
J Neuroendocrinol; 2005 Dec; 17(12):817-26. PubMed ID: 16280029
[TBL] [Abstract][Full Text] [Related]
8. Aldrin-induced locomotor activity: possible involvement of the central GABAergic-cholinergic-dopaminergic interaction.
Jamaluddin S; Poddar MK
Pol J Pharmacol; 2001; 53(1):21-30. PubMed ID: 11785907
[TBL] [Abstract][Full Text] [Related]
9. Behavioral changes after acetylcholinesterase inhibition with physostigmine in mice.
Mach M; Grubbs RD; Price WA; Paton SJ; Lucot JB
Pharmacol Biochem Behav; 2004 Nov; 79(3):533-40. PubMed ID: 15582025
[TBL] [Abstract][Full Text] [Related]
10. Presence of cholinomimetic and acetylcholinesterase inhibitory constituents in betel nut.
Gilani AH; Ghayur MN; Saify ZS; Ahmed SP; Choudhary MI; Khalid A
Life Sci; 2004 Oct; 75(20):2377-89. PubMed ID: 15350815
[TBL] [Abstract][Full Text] [Related]
11. The influence of calcium channel blockers on the central action of clonidine.
Czarnecka E; Tymczyszyn W
Pol J Pharmacol; 1994; 46(3):125-31. PubMed ID: 8000443
[TBL] [Abstract][Full Text] [Related]
12. Similar effects of nifedipine and hydralazine on anaesthesia and hypermotility induced by pentobarbitone in mice.
Sansone M; Pavone F; Battaglia M; Daniel W; Vetulani J
J Pharm Pharmacol; 1992 May; 44(5):453-5. PubMed ID: 1359066
[TBL] [Abstract][Full Text] [Related]
13. Central muscarinic inhibition of lower urinary tract nociception.
Thor KB; Muhlhauser MA; Sauerberg P; Shannon H; Springer JP
Brain Res; 2000 Jul; 870(1-2):126-34. PubMed ID: 10869509
[TBL] [Abstract][Full Text] [Related]
14. Morphine-induced place preference: involvement of cholinergic receptors of the ventral tegmental area.
Rezayof A; Nazari-Serenjeh F; Zarrindast MR; Sepehri H; Delphi L
Eur J Pharmacol; 2007 May; 562(1-2):92-102. PubMed ID: 17336285
[TBL] [Abstract][Full Text] [Related]
15. Role of voltage dependent calcium channels and cholinergic receptors in the convulsant action of BAY k-8644.
Wielosz M; Młynarczyk M; Kleinrok Z
Pol J Pharmacol; 1997; 49(5):369-71. PubMed ID: 9566038
[TBL] [Abstract][Full Text] [Related]
16. Central and peripheral muscarinic actions of physostigmine and oxotremorine on avoidance responding of squirrel monkeys.
Witkin JM
Psychopharmacology (Berl); 1989; 97(3):376-82. PubMed ID: 2497488
[TBL] [Abstract][Full Text] [Related]
17. Influence of cholinergic system modulators on morphine state-dependent memory of passive avoidance in mice.
Jafari MR; Zarrindast MR; Djahanguiri B
Physiol Behav; 2006 Jun; 88(1-2):146-51. PubMed ID: 16678225
[TBL] [Abstract][Full Text] [Related]
18. The effects of cholinergic agents on morphine-induced circling behavior in the intact mouse.
Seidel ER; Beaton JM; Teague RS
Eur J Pharmacol; 1979 Jun; 56(1-2):75-80. PubMed ID: 572778
[TBL] [Abstract][Full Text] [Related]
19. Oxotremorine-tolerance: muscarinic blockade or homeostatic adaptation?
György L
Acta Physiol Acad Sci Hung; 1979; 53(1):55-9. PubMed ID: 495126
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the effects of scopolamine on the habituation of exploratory activity: differential effects of oxotremorine and physostigmine.
Ukai M; Kobayashi T; Kameyama T
Gen Pharmacol; 1994 May; 25(3):433-8. PubMed ID: 7926587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
